This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Addus HomeCare Corporation (Nasdaq: ADUS) may slow down on mergers and acquisitions in the near term as it absorbs Gentiva’s personal care business. Addus provides personal care, homehealth and hospice to more than 48,500 patients across 22 states. Its hospice service line brought in $57.3 million that period.
Addus HomeCare Corporation (Nasdaq: ADUS) is anticipating slow-churning growth across its trifecta of home-based services. The company projected evolving hospice industry dynamics over the next year. Texas-headquartered Addus provides personal care, homehealth and hospice services in 23 states.
s (NASDAQ: AVAH) hospice and homehealth segments saw small jumps in the third quarter, but these lagged behind the company’s growth targets. The IPO occurred during a tumultuous era in health care, with providers across the continuum still reeling from the pandemic and worsened workforce pressures. rise from $411.3
Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its homehealth and personal care businesses. Texas-based Addus provides personal, homehealth and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.
Currently, nine of the company’s locations are hospices, with more expected in the coming years. Hospice is a smaller part of what we have today, but we’re excited to make that a bigger part and bring hospice into our other operating states. My roots are in home care. NYSE: EHAB). We’ll definitely see expansion.
Disruption in homehealth reimbursement has an influence on the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services. So many industry consolidators paused all but the most strategic deals and pivoted to hospice. “. A few factors come into play here.
While hospice and homehealth M&A continue to burgeon, non-medical home care is starting to slip out from under their shadows. Deal volume for non-medical home care companies outstripped that for hospice or homehealth during the first half of the year. Hospice market to stay mighty.
Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. This was Humana Inc.’s
Addus HomeCare Corporation (NASDAQ: ADUS) has acquired Chicago-based Apple Home Healthcare, Ltd., The state is one of three in which Addus offers its trifecta of business lines — personal care, homehealth and hospice. Hospice utilization in the Illinois market reached 50.3% for an undisclosed sum.
As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its homehealth and personal care services, with hospice becoming less of a priority.
The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards homehealth. Uncertainty earlier this year around Medicare’s proposed 2023 homehealth payment rates led some stakeholders to expect a swerve towards hospice.
The Future Leaders Awards program is brought to you in partnership with Homecare Homebase. The program is designed to recognize up-and-coming industry members who are shaping the next decade of homehealth, hospice care, senior housing, skilled nursing, and behavioral health. What drew you to this industry?
The Future Leaders Awards program is brought to you in partnership with Homecare Homebase. The program is designed to recognize up-and-coming industry members who are shaping the next decade of homehealth, hospice care, senior housing, skilled nursing, and behavioral health. I knew of the benefit.
. “We need to make sure that we continue to press [reimbursement] rates in order to pass those wages down to caregivers to entice them back into the home care space.”. Labor pressures continue to be the hospice industry’s biggest headwind. We do believe that Homecare Homebase will help us drive efficiencies as we go.
Hospice has emerged as a growth engine for publicly traded home-based care companies, several of which are on the hunt for acquisitions. Hospice has buoyed growth for several companies as they battle homehealth-related headwinds, including reimbursement pressures. We expect a 5% to 7% revenue growth for hospice.
Cara Lunsford, RN, Founder and CEO of HOLLIBLU and Vice President of Community at Relias, has long understood the physical and mental implications of providing homehealth nursing care. Homehealth and hospice can be challenging, and at times, come with some major safety concerns,” Lunsford explained.
For Immediate Release December 21, 2023 The National Association for Home Care & Hospice (NAHC) and the National Hospice & Palliative Care Organization (NHPCO) jointly announced today that they have developed a proposed slate of Transition Board of Directors and officers for 2024. Lloyd, MSN, RN, Delaware Hospice, Inc.,
Honing clinical scheduling and onboarding models is key to sustaining the hospice nurse workforce as demand for these clinicians rises and wages lag compared to those in other settings. Building sustainable models Effective and empathetic communication is among the key skills for hospice nurses to possess, White indicated.
She’s got a deep background in both homehealth and hospice, uh, from both a visiting nurse perspective, and then also management in both of those. So, uh, and now she currently is a colleague of ours at at Home Care Pulse, and, uh, is a, uh, nurse author. It’s, it’s very daunting.
Valuations in the hospice space have led Addus Homecare (Nasdaq: ADUS) to take a more conservative approach to hospice transactions as it actively seeks homehealth and personal care deals. Hospice multiples reach record highs in 2020 and 2021, as much as 26x. Hospice average length of stay reached 96.3
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content